HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 159 | 168 | 94.6% | |
| HF004 | 2020 | 149 | 161 | 92.5% | |
| HF006 | 2021 | 149 | 162 | 92.0% | |
| HF006 | 2022 | 157 | 165 | 95.2% | |
| HF006 | 2023 | 295 | 306 | 96.4% |
